Nifty

:

25235.90

Sensex

:

82365.77

83.95 (0.33%)
231.16 (0.28%)

Login

Nifty
Sensex

:
:

25235.90
82365.77

83.95 (0.33%)
231.16 (0.28%)

Aarti Pharmalabs Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543748 | NSE: AARTIPHARM

Watchlist

NSE BSE

622.85

05-Jul-2024

Open
High
Low
Previous Close

615.20
631.60
613.60
615.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

146814
914.94
721.70
371.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,235.98
27.68
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,476.01
0.44%
3.44

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
13.47

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
21.06

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 393.49 358.14 9.87% 414.82 374.27 10.83% 373.03 359.33 3.81% 356.14 404.50 -11.96%
Expenses 309.83 281.40 10.10% 307.48 297.47 3.37% 284.75 286.77 -0.70% 282.34 324.24 -12.92%
EBITDA 83.65 76.74 9.00% 107.34 76.80 39.77% 88.28 72.56 21.66% 73.80 80.26 -8.05%
EBIDTM 21.26% 21.43% 25.88% 20.52% 23.67% 20.19% 20.72% 19.84%
Other Income 2.11 4.86 -56.58% 5.68 0.00 0 0.20 0.04 400.00% 0.00 1.24 -100.00%
Interest 4.25 4.03 5.46% 4.42 5.80 -23.79% 4.10 5.12 -19.92% 3.82 5.52 -30.80%
Depreciation 18.29 15.44 18.46% 17.32 14.25 21.54% 16.94 14.56 16.35% 16.32 14.55 12.16%
PBT 63.23 62.13 1.77% 91.28 56.75 60.85% 67.44 52.92 27.44% 53.66 61.43 -12.65%
Tax 16.08 14.50 10.90% 28.26 16.76 68.62% 19.25 14.38 33.87% 11.85 15.50 -23.55%
PAT 47.14 47.63 -1.03% 63.02 39.99 57.59% 48.19 38.54 25.04% 41.81 45.93 -8.97%
PATM 11.98% 13.30% 15.19% 10.68% 12.92% 10.73% 11.74% 11.35%
EPS 5.20 5.26 -1.14% 6.96 4.41 57.82% 5.32 4.25 25.18% 4.61 5.07 -9.07%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 555.49 458.36 21.19% 505.77 485.06 4.27% 448.69 471.62 -4.86% 439.80 531.17 -17.20%
Expenses 459.03 373.49 22.90% 388.25 405.07 -4.15% 353.01 385.38 -8.40% 351.81 441.40 -20.30%
EBITDA 96.46 84.87 13.66% 117.52 79.99 46.92% 95.68 86.24 10.95% 87.99 89.77 -1.98%
EBIDTM 17.36% 18.52% 23.24% 16.49% 21.32% 18.29% 20.01% 16.90%
Other Income 2.22 0.48 362.50% 2.03 0.74 174.32% 1.39 0.29 379.31% 0.98 1.28 -23.44%
Interest 4.83 4.17 15.83% 4.68 5.94 -21.21% 4.48 5.25 -14.67% 3.89 5.63 -30.91%
Depreciation 20.17 17.20 17.27% 19.12 15.95 19.87% 18.77 16.25 15.51% 18.14 16.57 9.47%
PBT 73.68 63.98 15.16% 95.75 58.84 62.73% 73.82 65.03 13.52% 66.94 68.85 -2.77%
Tax 18.22 16.88 7.94% 30.50 15.97 90.98% 21.06 17.34 21.45% 15.14 17.76 -14.75%
PAT 55.45 47.09 17.75% 65.25 42.87 52.20% 52.76 47.69 10.63% 51.80 51.09 1.39%
PATM 9.98% 10.27% 12.90% 8.84% 11.76% 10.11% 11.78% 9.62%
EPS 6.12 5.20 17.69% 7.20 4.73 52.22% 5.82 5.26 10.65% 5.72 5.64 1.42%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 1,537.48 1,502.13 1,511.25 941.02 Net Sales Growth 2.76% -0.60% 60.60% Cost Of Goods Sold 766.77 751.97 817.93 451.66 Gross Profit 770.71 750.16 693.32 489.36 GP Margin 50.13% 49.94% 45.88% 52.00% Total Expenditure 1,184.40 1,155.97 1,202.91 761.24 Power & Fuel Cost - 82.92 74.22 69.73 % Of Sales - 5.52% 4.91% 7.41% Employee Cost - 120.15 113.92 79.98 % Of Sales - 8.00% 7.54% 8.50% Manufacturing Exp. - 99.70 96.20 132.62 % Of Sales - 6.64% 6.37% 14.09% General & Admin Exp. - 28.39 29.30 6.98 % Of Sales - 1.89% 1.94% 0.74% Selling & Distn. Exp. - 49.19 48.54 20.25 % Of Sales - 3.27% 3.21% 2.15% Miscellaneous Exp. - 23.65 22.80 0.01 % Of Sales - 1.57% 1.51% 0.00% EBITDA 353.07 346.16 308.34 179.78 EBITDA Margin 22.96% 23.04% 20.40% 19.10% Other Income 7.99 11.01 1.28 2.51 Interest 16.59 16.63 20.49 11.34 Depreciation 68.87 66.01 55.77 37.23 PBT 275.61 274.52 233.36 133.73 Tax 75.44 73.87 61.63 27.00 Tax Rate 27.37% 26.91% 26.41% 20.19% PAT 200.16 200.65 171.73 106.73 PAT before Minority Interest 200.16 200.65 171.73 106.73 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 13.02% 13.36% 11.36% 11.34% PAT Growth 16.31% 16.84% 60.90% EPS 22.09 22.15 18.95 11.78

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 1,949.75 1,852.61 1,945.23 1,199.94 Net Sales Growth 0.18% -4.76% 62.11% Cost Of Goods Sold 1,088.04 1,020.71 1,169.76 637.67 Gross Profit 861.71 831.89 775.48 562.27 GP Margin 44.20% 44.90% 39.87% 46.86% Total Expenditure 1,552.10 1,466.56 1,603.18 994.67 Power & Fuel Cost - 84.03 75.10 90.00 % Of Sales - 4.54% 3.86% 7.50% Employee Cost - 128.03 121.32 85.20 % Of Sales - 6.91% 6.24% 7.10% Manufacturing Exp. - 107.30 98.78 145.95 % Of Sales - 5.79% 5.08% 12.16% General & Admin Exp. - 30.08 30.20 8.13 % Of Sales - 1.62% 1.55% 0.68% Selling & Distn. Exp. - 68.88 74.83 27.38 % Of Sales - 3.72% 3.85% 2.28% Miscellaneous Exp. - 27.53 33.20 0.34 % Of Sales - 1.49% 1.71% 0.03% EBITDA 397.65 386.05 342.05 205.27 EBITDA Margin 20.39% 20.84% 17.58% 17.11% Other Income 6.62 4.89 2.32 4.19 Interest 17.88 17.21 21.05 11.96 Depreciation 76.20 73.24 62.54 42.12 PBT 310.19 300.49 260.77 155.38 Tax 84.92 83.59 67.28 33.13 Tax Rate 27.38% 27.82% 25.80% 21.32% PAT 225.26 216.90 193.49 122.25 PAT before Minority Interest 225.26 216.90 193.49 122.25 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 11.55% 11.71% 9.95% 10.19% PAT Growth 19.35% 12.10% 58.27% EPS 24.86 23.94 21.36 13.49

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,621.46 1,438.58 1,284.28 Share Capital 45.31 45.31 0.25 Total Reserves 1,575.92 1,393.27 1,238.71 Non-Current Liabilities 119.87 74.04 60.88 Secured Loans 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 5.28 4.66 0.00 Current Liabilities 555.58 463.75 481.67 Trade Payables 254.79 212.50 131.61 Other Current Liabilities 43.76 36.20 8.98 Short Term Borrowings 250.80 206.71 324.62 Short Term Provisions 6.24 8.33 16.46 Total Liabilities 2,296.91 1,976.37 1,826.83 Net Block 953.33 848.40 701.12 Gross Block 1,472.15 1,303.76 1,100.71 Accumulated Depreciation 518.82 455.37 399.59 Non Current Assets 1,162.85 1,010.15 936.56 Capital Work in Progress 136.92 101.90 187.37 Non Current Investment 43.83 42.67 39.87 Long Term Loans & Adv. 28.77 17.18 8.21 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,134.06 966.22 890.27 Current Investments 17.83 12.81 0.00 Inventories 582.15 537.68 444.38 Sundry Debtors 448.82 371.67 304.22 Cash & Bank 4.43 0.37 56.50 Other Current Assets 80.83 7.18 11.53 Short Term Loans & Adv. 66.86 36.51 73.65 Net Current Assets 578.48 502.47 408.60 Total Assets 2,296.91 1,976.37 1,826.83

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,757.04 1,558.49 1,386.48 Share Capital 45.31 45.31 0.25 Total Reserves 1,711.50 1,513.17 1,340.91 Non-Current Liabilities 130.68 84.91 72.76 Secured Loans 0.04 0.18 0.55 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 6.06 5.36 0.00 Current Liabilities 694.39 600.62 580.67 Trade Payables 378.32 339.50 214.59 Other Current Liabilities 45.84 38.33 11.89 Short Term Borrowings 263.92 213.78 337.73 Short Term Provisions 6.31 9.01 16.46 Total Liabilities 2,582.11 2,244.02 2,039.91 Net Block 1,033.33 925.84 782.09 Gross Block 1,609.29 1,431.25 1,225.00 Accumulated Depreciation 575.96 505.41 442.90 Non Current Assets 1,236.46 1,081.02 1,011.75 Capital Work in Progress 136.92 101.87 187.37 Non Current Investment 36.78 35.52 32.23 Long Term Loans & Adv. 29.44 17.78 10.07 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,345.64 1,163.01 1,028.15 Current Investments 70.39 50.99 0.00 Inventories 642.86 602.04 475.45 Sundry Debtors 519.34 450.10 376.66 Cash & Bank 24.07 12.19 83.27 Other Current Assets 88.98 7.70 10.74 Short Term Loans & Adv. 71.97 39.98 82.03 Net Current Assets 651.25 562.38 447.48 Total Assets 2,582.10 2,244.03 2,039.90

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 183.69 215.88 -64.84 PBT 274.52 233.36 133.73 Adjustment 80.71 76.87 46.08 Changes in Working Capital -124.55 -37.61 -229.65 Cash after chg. in Working capital 230.68 272.61 -49.84 Interest Paid 0.00 0.00 0.00 Tax Paid -46.99 -56.73 -15.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -184.40 -115.55 -133.54 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others 25.19 17.64 Cash from Financing Activity 4.40 -156.53 254.63 Net Cash Inflow / Outflow 3.70 -56.20 56.25 Opening Cash & Equivalents 0.30 56.50 0.25 Closing Cash & Equivalent 4.00 0.30 56.50

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 216.35 250.12 -43.70 PBT 300.49 260.77 155.38 Adjustment 94.65 83.35 52.41 Changes in Working Capital -121.85 -31.63 -230.36 Cash after chg. in Working capital 273.29 312.50 -22.57 Interest Paid 0.00 0.00 0.00 Tax Paid -56.94 -62.38 -21.13 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -214.56 -157.80 -138.74 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others -4.97 -24.61 Cash from Financing Activity 9.72 -163.46 260.38 Net Cash Inflow / Outflow 11.51 -71.15 77.94 Opening Cash & Equivalents 12.12 83.27 5.33 Closing Cash & Equivalent 23.63 12.12 83.27

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 178.89 158.74 49558.52 ROA 9.39% 9.03% 11.68% ROE 13.11% 12.83% 17.23% ROCE 16.55% 15.60% 18.03% Fixed Asset Turnover 1.08 1.26 0.85 Receivable days 99.68 81.62 118.00 Inventory Days 136.05 118.59 172.36 Payable days 113.41 76.78 53.18 Cash Conversion Cycle 122.33 123.44 237.18 Total Debt/Equity 0.15 0.14 0.26 Interest Cover 17.50 12.39 12.79

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 193.85 171.97 53646.60 ROA 8.99% 9.03% 11.98% ROE 13.08% 13.35% 18.23% ROCE 16.75% 16.11% 19.40% Fixed Asset Turnover 1.22 1.46 0.98 Receivable days 95.50 77.57 114.57 Inventory Days 122.63 101.09 144.62 Payable days 128.34 86.45 61.41 Cash Conversion Cycle 89.79 92.21 197.78 Total Debt/Equity 0.15 0.14 0.25 Interest Cover 18.46 13.39 13.99

Top Investors:

life insurance corporation of india

ntasain discovery master fund

nishant pradip shah

aditya birla sun life trustee private limited a/c aditya birla sun life flexi cap fund

morgan stanley investment funds emerging leaders equity fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Aarti Pharmalabs - Quarterly Results
5th Aug 2024, 15:38 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback